SEC Form 4 · accession 0001140361-17-011682
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Kramer
Officer — EVP, Corproate Services Div
Period of report
Mar 9, 2017
Accepted (ET)
Mar 10, 2017 · 9:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 9, 2017 | F | 1,908 | $30.98 | D | 85,102 | D | |
| Common StockF1 | Mar 10, 2017 | F | 3,007 | $31.05 | D | 82,095 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.